source
- Ferring agrees to buy fertility startup Gameto in deal up to $1.38 billionFerring Pharmaceuticals announced it has signed an agreement to acquire Gameto, a biotech company developing an ovary-in-a-dish platform for fertility treatments. The transaction is structured as…
- Novartis weighs private-pay launches in Europe as MFN rules pressure government pricingNovartis CEO Vas Narasimhan said the company is exploring the option of introducing new medicines directly to private or self‑pay patients in Europe. The discussion is driven by the European Union…